Johnson Controls insider files Form 144 to sell 5,917 shares on NYSE

Rhea-AI Filing Summary

Johnson Controls International plc (JCI) Form 144 notifies a proposed SALE of 5,917 shares of common stock to be executed through Morgan Stanley Smith Barney LLC on 09/03/2025 on the NYSE. The filer reports the shares were acquired the same day by exercise of options under a registered plan and paid in cash. The filing shows an aggregate market value of $625,594.94 and lists the company’s total shares outstanding as 654,385,440, making the proposed sale a very small fraction of outstanding equity. No other securities sales in the past three months are reported.

Positive

• Timely regulatory disclosure via Form 144 for the proposed sale
• Transaction arose from exercise of options under a registered plan, which is a standard, non-speculative source of shares
• Small size relative to outstanding shares (5,917 versus 654,385,440) suggesting immaterial market impact
• No other securities sold in past three months reported by the filer

Negative

• None.

Insights

Securities/Financial Analyst

TL;DR Insider exercised options and intends to sell a de minimis number of shares; unlikely to move market sentiment.

The filing documents a routine insider transaction: 5,917 shares acquired by option exercise and proposed for immediate sale through a registered broker on the NYSE. The aggregate value of $625,594.94 versus 654,385,440 outstanding shares implies an immaterial dilution/flow relative to market capitalization. This is consistent with portfolio liquidity actions rather than a signal of material operational change. The absence of other sales in the past three months supports limited recent insider disposition activity.

Compliance / Corporate Governance Specialist

TL;DR Form 144 appears properly completed for a single, registered-plan option exercise sale; filing supports regulatory transparency.

The notice records acquisition by exercise under a registered plan and cash payment on the same date, and names Morgan Stanley Smith Barney LLC as broker, which aligns with standard Rule 144 reporting. The filer includes the required representation about absence of undisclosed material adverse information. No prior three-month sales are reported, and remarks/signature sections are present, indicating the filer complied with disclosure formalities. The filing does not contain additional issuer-specific details.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5917	625594.94	654385440	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/03/2025	Exercise of options under a registered plan	Issuer			5917	09/03/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the JCI Form 144 propose to sell?

The notice proposes sale of 5,917 shares of common stock.

When and where is the proposed sale scheduled?

The proposed sale is dated 09/03/2025 and lists the NYSE as the exchange, executed through Morgan Stanley Smith Barney LLC.

How were the shares acquired according to the filing?

The shares were acquired on 09/03/2025 by exercise of options under a registered plan and paid in cash.

What is the aggregate market value of the proposed sale?

The filing reports an aggregate market value of $625,594.94 for the 5,917 shares.

Does the filing show other recent sales by the filer?

No; the section for securities sold during the past three months states Nothing to Report.